VenkataramanKalyanaramanMD(He/Him)

Adrenal Disease, Diabetes, Lipid Metabolism, Obesity

Associate Chief of Staff, Endocrinologist.

Dr. Kalyanaraman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
VA North Texas Health Care System - Dallas VA Medical Center
4500 S Lancaster Rd
Dallas, TX 75216

Board certified endocrinologist vast experience in thyroid disorders and biopsy bone densitometry obesity management adrenal disorders and pituitary disease. More than 9yrs experience in clinical and administration. Worked in executive position at VA. Primary Investigator of various grants from CDC, IHS, Metabolic care center Director, OKCIC.

University of Oklahoma Health Sciences CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2006 - 2008
Zucker School of Medicine at Hofstra/NorthwellFellowship, Pulmonary Disease and Critical Care Medicine, 1997 - 1998
Zucker School of Medicine at Hofstra/Northwell at Forest Hills HospitalResidency, Internal Medicine, 1994 - 1997
Kilpauk Medical CollegeClass of 1992

Diabetes disease state network AACE, 2020
Bone and Parathyroid Disease State Network Diabetes Disease State Network Pituitary, Gonad, Adrenal and Neuroendocrine Disease State Network AACE
AACE political liaison AACE

PubMed

15 citations
Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetes
Yongxin Jeremy Yu, Kristian F. Hanssen, V. Kalyanaraman, A. Chirindel, Alicia J. Jenkins
BJOG. 2012-11-01
Difficulties in monitoring the glucose status of patients undergoing hematopoietic stem cell transplantation.
George B. Selby, Melody Mosallaei-Benjamin, Venkataraman Kalyanaraman, Andrew Lancaster, R. H. Scofield
Biology of Blood and Marrow Transplantation. 2009-08-01

Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetesReduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetes PMID: 22900949 PMCID: PMC3980671 DOI: 10.1111/j.1471-0528.2012.03463.x2006 - 2009
ResearcherGlucose status of patients undergoing hematopoietic stem cell transplantation PMID: 19589491 DOI: 10.1016/j.bbmt.2009.05.0022007 - 2008